{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:13:47Z","timestamp":1790792027016,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Atherosclerotic cardio-cerebrovascular disease and death remain the leading cause of morbidity and mortality worldwide. Defective efferocytosis, the clearance of apoptotic cells by macrophages, is thought to lead to increased inflammation and necrotic core formation in atherosclerotic lesions. However, very little is known about the role of long noncoding RNA (lncRNA) during this process. Here we show that lncRNA myocardial infarction associated transcript (MIAT) was markedly elevated in the serum of patients with symptoms of vulnerable atherosclerotic plaque and the macrophages of necrotic cores in an advanced atherosclerosis mouse model. MIAT knockdown attenuated atherosclerosis progression, reduced necrotic core size, and increased plaque stability in vivo. Furthermore, MIAT knockdown promoted clearance of apoptotic cells by macrophages in vivo and in vitro. Mechanistic studies revealed that MIAT acted as a micro RNA (miRNA) sponge to positively modulate the expression of anti-phagocytic molecule CD47 through sponging miR-149-5p. Together, these findings identified a macrophage MIAT\/miR-149-5p \/CD47 pathway as a key factor in the development of necrotic atherosclerotic plaques.<\/jats:p>","DOI":"10.1038\/s41419-019-1409-4","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T07:05:57Z","timestamp":1549955157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":179,"title":["LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation"],"prefix":"10.1038","volume":"10","author":[{"given":"Zi-ming","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-peng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-ting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengcai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-ying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,12]]},"reference":[{"key":"1409_CR1","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","volume":"382","author":"FG Fowkes","year":"2013","unstructured":"Fowkes, F. G. et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382, 1329\u20131340 (2013).","journal-title":"Lancet"},{"key":"1409_CR2","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119\u20131131 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1409_CR3","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1093\/eurheartj\/ehv508","volume":"36","author":"K Toutouzas","year":"2015","unstructured":"Toutouzas, K. et al. Vulnerable plaque imaging: updates on new pathobiological mechanisms. Eur. Heart J. 36, 3147\u20133154 (2015).","journal-title":"Eur. Heart J."},{"key":"1409_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1161\/CIRCULATIONAHA.116.026859","volume":"136","author":"JB Lerman","year":"2017","unstructured":"Lerman, J. B. et al. Coronary plaque characterization in psoriasis reveals high-risk features that improve after treatment in a prospective observational study. Circulation 136, 263\u2013276 (2017).","journal-title":"Circulation"},{"key":"1409_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","volume":"172","author":"F Kopp","year":"2018","unstructured":"Kopp, F. & Mendell, J. T. Functional classification and experimental dissection of long noncoding RNAs. Cell 172, 393\u2013407 (2018).","journal-title":"Cell"},{"key":"1409_CR6","doi-asserted-by":"publisher","unstructured":"Kumar, S., Williams, D., Sur, S., Wang, J. Y. & Jo, H. Role of flow-sensitive microRNAs and long noncoding RNAs and in vascular dysfunction and atherosclerosis. Vascul. Pharmacol. https:\/\/doi.org\/10.1016\/j.vph.2018.10.001 (2018).","DOI":"10.1016\/j.vph.2018.10.001"},{"key":"1409_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1161\/CIRCRESAHA.117.311802","volume":"122","author":"T Sallam","year":"2018","unstructured":"Sallam, T., Sandhu, J. & Tontonoz, P. Long noncoding RNA discovery in cardiovascular disease: decoding form to function. Circ. Res. 122, 155\u2013166 (2018).","journal-title":"Circ. Res."},{"key":"1409_CR8","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/aps.2017.196","volume":"39","author":"AS Bayoumi","year":"2018","unstructured":"Bayoumi, A. S., Aonuma, T., Teoh, J. P., Tang, Y. L. & Kim, I. M. Circular noncoding RNAs as potential therapies and circulating biomarkers for cardiovascular diseases. Acta Pharmacol. Sin. 39, 1100\u20131109 (2018).","journal-title":"Acta Pharmacol. Sin."},{"key":"1409_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1161\/CIRCRESAHA.117.311311","volume":"123","author":"T Lucas","year":"2018","unstructured":"Lucas, T., Bonauer, A. & Dimmeler, S. RNA therapeutics in cardiovascular disease. Circ. Res. 123, 205\u2013220 (2018).","journal-title":"Circ. Res."},{"key":"1409_CR10","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/mp.2013.45","volume":"19","author":"G Barry","year":"2014","unstructured":"Barry, G. et al. The long non-coding RNA Gomafu is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing. Mol. Psychiatry 19, 486\u2013494 (2014).","journal-title":"Mol. Psychiatry"},{"key":"1409_CR11","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1161\/CIRCRESAHA.116.305510","volume":"116","author":"B Yan","year":"2015","unstructured":"Yan, B. et al. lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA. Circ. Res. 116, 1143\u20131156 (2015).","journal-title":"Circ. Res."},{"key":"1409_CR12","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1161\/CIRCRESAHA.115.303836","volume":"115","author":"M Vausort","year":"2014","unstructured":"Vausort, M., Wagner, D. R. & Devaux, Y. Long noncoding RNAs in patients with acute myocardial infarction. Circ. Res. 115, 668\u2013677 (2014).","journal-title":"Circ. Res."},{"key":"1409_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12929-018-0427-3","volume":"25","author":"C Sun","year":"2018","unstructured":"Sun, C. et al. Long non-coding RNA MIAT in development and disease: a new player in an old game. J. Biomed. Sci. 25, 23 (2018).","journal-title":"J. Biomed. Sci."},{"key":"1409_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.atherosclerosis.2017.10.012","volume":"266","author":"S Arslan","year":"2017","unstructured":"Arslan, S. et al. Long non-coding RNAs in the atherosclerotic plaque. Atherosclerosis 266, 176\u2013181 (2017).","journal-title":"Atherosclerosis"},{"key":"1409_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.09.009","volume":"27","author":"M Zhu","year":"2018","unstructured":"Zhu, M. et al. Peripheral blood leukocyte expression of lncRNA MIAT and its diagnostic and prognostic value in ischemic stroke. J. Stroke Cerebrovasc. Dis. 27, 326\u2013337 (2018).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"1409_CR16","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41590-018-0113-3","volume":"19","author":"GJ Koelwyn","year":"2018","unstructured":"Koelwyn, G. J., Corr, E. M., Erbay, E. & Moore, K. J. Regulation of macrophage immunometabolism in atherosclerosis. Nat. Immunol. 19, 526\u2013537 (2018).","journal-title":"Nat. Immunol."},{"key":"1409_CR17","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.immuni.2017.09.008","volume":"47","author":"I Tabas","year":"2017","unstructured":"Tabas, I. & Lichtman, A. H. Monocyte-macrophages and T cells in atherosclerosis. Immunity 47, 621\u2013634 (2017).","journal-title":"Immunity"},{"key":"1409_CR18","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1172\/JCI97950","volume":"128","author":"C Kasikara","year":"2018","unstructured":"Kasikara, C., Doran, A. C., Cai, B. & Tabas, I. The role of non-resolving inflammation in atherosclerosis. J. Clin. Invest. 128, 2713\u20132723 (2018).","journal-title":"J. Clin. Invest."},{"key":"1409_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1161\/CIRCRESAHA.114.302355","volume":"114","author":"C Silvestre-Roig","year":"2014","unstructured":"Silvestre-Roig, C. et al. Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies. Circ. Res. 114, 214\u2013226 (2014).","journal-title":"Circ. Res."},{"key":"1409_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev-cellbio-111315-125315","volume":"33","author":"PM Henson","year":"2017","unstructured":"Henson, P. M. Cell removal: efferocytosis. Annu. Rev. Cell. Dev. Biol. 33, 127\u2013144 (2017).","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"key":"1409_CR21","doi-asserted-by":"publisher","unstructured":"Proto, J. D. et al. Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution. Immunity, https:\/\/doi.org\/10.1016\/j.immuni.2018.07.015 (2018).","DOI":"10.1016\/j.immuni.2018.07.015"},{"key":"1409_CR22","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1172\/JCI94735","volume":"127","author":"AC Doran","year":"2017","unstructured":"Doran, A. C. et al. CAMKIIgamma suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis. J. Clin. Invest. 127, 4075\u20134089 (2017).","journal-title":"J. Clin. Invest."},{"key":"1409_CR23","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1161\/CIRCULATIONAHA.117.027844","volume":"136","author":"AN Seneviratne","year":"2017","unstructured":"Seneviratne, A. N. et al. Interferon regulatory factor 5 controls necrotic core formation in atherosclerotic lesions by impairing efferocytosis. Circulation 136, 1140\u20131154 (2017).","journal-title":"Circulation"},{"key":"1409_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nature18935","volume":"536","author":"Y Kojima","year":"2016","unstructured":"Kojima, Y. et al. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature 536, 86\u201390 (2016).","journal-title":"Nature"},{"key":"1409_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/imr.12527","volume":"276","author":"HL Matlung","year":"2017","unstructured":"Matlung, H. L., Szilagyi, K., Barclay, N. A. & van den Berg, T. K. The CD47-SIRPalpha signaling axis as an innate immune checkpoint in cancer. Immunol. Rev. 276, 145\u2013164 (2017).","journal-title":"Immunol. Rev."},{"key":"1409_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejca.2017.02.013","volume":"76","author":"K Weiskopf","year":"2017","unstructured":"Weiskopf, K. Cancer immunotherapy targeting the CD47\/SIRP\u03b1 axis. Eur. J. Cancer 76, 100\u2013109 (2017).","journal-title":"Eur. J. Cancer"},{"key":"1409_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nri2761","volume":"10","author":"AC Chan","year":"2010","unstructured":"Chan, A. C. & Carter, P. J. Therapeutic antibodies for autoimmunity and inflammation. Nat. Rev. Immunol. 10, 301\u2013316 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"1409_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cmet.2013.06.003","volume":"18","author":"M Dong","year":"2013","unstructured":"Dong, M. et al. Cold exposure promotes atherosclerotic plaque growth and instability via UCP1-dependent lipolysis. Cell Metab. 18, 118\u2013129 (2013).","journal-title":"Cell Metab."},{"key":"1409_CR29","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1126\/science.aad8709","volume":"352","author":"BA Sullenger","year":"2016","unstructured":"Sullenger, B. A. & Nair, S. From the RNA world to the clinic. Science 352, 1417\u20131420 (2016).","journal-title":"Science"},{"key":"1409_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01781-0","volume":"8","author":"R Mitra","year":"2017","unstructured":"Mitra, R. et al. Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition. Nat. Commun. 8, 1604 (2017).","journal-title":"Nat. Commun."},{"key":"1409_CR31","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/nm.4479","volume":"24","author":"T Sallam","year":"2018","unstructured":"Sallam, T. et al. Transcriptional regulation of macrophage cholesterol efflux and atherogenesis by a long noncoding RNA. Nat. Med. 24, 304\u2013312 (2018).","journal-title":"Nat. Med."},{"key":"1409_CR32","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/nature17674","volume":"534","author":"T Sallam","year":"2016","unstructured":"Sallam, T. et al. Feedback modulation of cholesterol metabolism by the lipid-responsive non-coding RNA LeXis. Nature 534, 124\u2013128 (2016).","journal-title":"Nature"},{"key":"1409_CR33","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1161\/CIRCULATIONAHA.115.021019","volume":"133","author":"MD Ballantyne","year":"2016","unstructured":"Ballantyne, M. D. et al. Smooth muscle enriched long noncoding RNA (SMILR) regulates cell proliferation. Circulation 133, 2050\u20132065 (2016).","journal-title":"Circulation"},{"key":"1409_CR34","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.4049\/jimmunol.1600305","volume":"198","author":"M Benagiano","year":"2017","unstructured":"Benagiano, M. et al. \u03b22 glycoprotein I recognition drives th1 inflammation in atherosclerotic plaques of patients with primary antiphospholipid syndrome. J. immunol. 198, 2640\u20132648 (2017).","journal-title":"J. immunol."},{"key":"1409_CR35","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1161\/CIRCRESAHA.116.308398","volume":"120","author":"AK Boehme","year":"2017","unstructured":"Boehme, A. K., Esenwa, C. & Elkind, M. S. Stroke risk factors, genetics, and prevention. Circ. Res. 120, 472\u2013495 (2017).","journal-title":"Circ. Res."},{"key":"1409_CR36","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","volume":"118","author":"AM Wendelboe","year":"2016","unstructured":"Wendelboe, A. M. & Raskob, G. E. Global burden of thrombosis: epidemiologic aspects. Circ. Res. 118, 1340\u20131347 (2016).","journal-title":"Circ. Res."},{"key":"1409_CR37","doi-asserted-by":"publisher","first-page":"e2929","DOI":"10.1038\/cddis.2017.321","volume":"8","author":"X Zhou","year":"2017","unstructured":"Zhou, X. et al. lncRNA MIAT functions as a competing endogenous RNA to upregulate DAPK2 by sponging miR-22-3p in diabetic cardiomyopathy. Cell Death Dis. 8, e2929 (2017).","journal-title":"Cell Death Dis."},{"key":"1409_CR38","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/jcmm.12755","volume":"20","author":"Y Shen","year":"2016","unstructured":"Shen, Y. et al. Role of long non-coding RNA MIAT in proliferation, apoptosis and migration of lens epithelial cells: a clinical and in vitro study. J. Cell. Mol. Med. 20, 537\u2013548 (2016).","journal-title":"J. Cell. Mol. Med."},{"key":"1409_CR39","doi-asserted-by":"crossref","first-page":"49688","DOI":"10.18632\/oncotarget.10434","volume":"7","author":"Q Jiang","year":"2016","unstructured":"Jiang, Q. et al. Long non-coding RNA-MIAT promotes neurovascular remodeling in the eye and brain. Oncotarget 7, 49688\u201349698 (2016).","journal-title":"Oncotarget"},{"key":"1409_CR40","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1172\/JCI84424","volume":"127","author":"BD Adams","year":"2017","unstructured":"Adams, B. D., Parsons, C., Walker, L., Zhang, W. C. & Slack, F. J. Targeting noncoding RNAs in disease. J. Clin. Invest. 127, 761\u2013771 (2017).","journal-title":"J. Clin. Invest."},{"key":"1409_CR41","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay, Y., Rinn, J. & Pandolfi, P. P. The multilayered complexity of ceRNA crosstalk and competition. Nature 505, 344\u2013352 (2014).","journal-title":"Nature"},{"key":"1409_CR42","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrg.2016.20","volume":"17","author":"DW Thomson","year":"2016","unstructured":"Thomson, D. W. & Dinger, M. E. Endogenous microRNA sponges: evidence and controversy. Nat. Rev. Genet. 17, 272\u2013283 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"1409_CR43","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cell.2011.09.028","volume":"147","author":"M Cesana","year":"2011","unstructured":"Cesana, M. et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147, 358\u2013369 (2011).","journal-title":"Cell"},{"key":"1409_CR44","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12933-017-0592-9","volume":"16","author":"B Sun","year":"2017","unstructured":"Sun, B. et al. Association between carotid plaque characteristics and acute cerebral infarction determined by MRI in patients with type 2 diabetes mellitus. Cardiovasc. Diabetol. 16, 111 (2017).","journal-title":"Cardiovasc. Diabetol."},{"key":"1409_CR45","doi-asserted-by":"publisher","unstructured":"Zhao, X. et al. Prevalence and characteristics of carotid artery high-risk atherosclerotic plaques in chinese patients with cerebrovascular symptoms: a chinese atherosclerosis risk evaluation II study. J. Am. Heart Assoc. 6, https:\/\/doi.org\/10.1161\/jaha.117.005831 (2017).","DOI":"10.1161\/jaha.117.005831"},{"key":"1409_CR46","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1161\/01.CIR.0000028591.44554.F9","volume":"106","author":"JM Cai","year":"2002","unstructured":"Cai, J. M. et al. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation 106, 1368\u20131373 (2002).","journal-title":"Circulation"},{"key":"1409_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12968-016-0229-2","volume":"18","author":"T Saam","year":"2016","unstructured":"Saam, T. et al. Expansive arterial remodeling of the carotid arteries and its effect on atherosclerotic plaque composition and vulnerability: an in-vivo black-blood 3T CMR study in symptomatic stroke patients. J. Cardiovasc. Magn. Reson. 18, 11 (2016).","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"1409_CR48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.yjmcc.2018.09.004","volume":"123","author":"S Yang","year":"2018","unstructured":"Yang, S. et al. MicroRNA-23a-5p promotes atherosclerotic plaque progression and vulnerability by repressing ATP-binding cassette transporter A1\/G1 in macrophages. J. Mol. Cell. Cardiol. 123, 139\u2013149 (2018).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"1409_CR49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jim.2017.04.009","volume":"447","author":"D Takahashi","year":"2017","unstructured":"Takahashi, D. et al. Flow cytometric quantitation of platelet phagocytosis by monocytes using a pH-sensitive dye, pHrodo-SE. J. Immunol. Methods 447, 57\u201364 (2017).","journal-title":"J. Immunol. Methods"},{"key":"1409_CR50","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nature22076","volume":"544","author":"J Chen","year":"2017","unstructured":"Chen, J. et al. SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin. Nature 544, 493\u2013497 (2017).","journal-title":"Nature"},{"key":"1409_CR51","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/15548627.2014.998904","volume":"11","author":"P Crauwels","year":"2015","unstructured":"Crauwels, P. et al. Apoptotic-like Leishmania exploit the host\u2019s autophagy machinery to reduce T-cell-mediated parasite elimination. Autophagy 11, 285\u2013297 (2015).","journal-title":"Autophagy"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1409-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1409-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1409-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T11:31:38Z","timestamp":1671190298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1409-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,12]]},"references-count":51,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2]]}},"alternative-id":["1409"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-1409-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,12]]},"assertion":[{"value":"21 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"138"}}